Discovering DNA methylation patterns for long non-coding RNAs associated with cancer subtypes

Area of Science:

• Genomics
• Cancer Biology
• Epigenetics

Background:

• Long non-coding RNAs (lncRNAs) are crucial in cancer development.
• Understanding DNA methylation patterns of lncRNAs is limited.
• Breast cancer comprises distinct molecular subtypes with varied prognoses.

Purpose of the Study:

• To develop a pipeline for discovering DNA methylation patterns of lncRNAs across breast cancer subtypes.
• To identify subtype-specific and common lncRNA methylation modules.
• To evaluate the utility of lncRNA modules as biomarkers for prediction and therapy.

Main Methods:

• Utilized The Cancer Genome Atlas (TCGA) breast cancer methylation data.
• Developed a systematic analysis pipeline for probe, gene, and network-level analysis.
• Constructed differential co-methylation lncRNA networks for each subtype.

Main Results:

• Discovered diverse DNA methylation patterns for lncRNAs across luminal A, luminal B, HER2-enriched, and basal-like breast cancer subtypes.
• Identified subtype-specific and common lncRNA modules with distinct characteristics.
• Demonstrated that lncRNA modules significantly improve breast cancer subtype prediction accuracy.
• Showed common lncRNA modules correlate with patient survival time.

Conclusions:

• lncRNA DNA methylation patterns are specific to breast cancer subtypes.
• Subtype-specific lncRNA modules can serve as novel biomarkers for improved diagnosis.
• Common lncRNA modules highlight potential therapeutic targets for cancer treatment.